Ally Bridge Group (NY) LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$110.9B
Holdings
28
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 281,139 | $12.4B | 11.18% | |
| 2 | VRNAVERONA PHARMA PLC - ADR | 139,067 | $8.8B | 7.96% | |
| 3 | SLNOSOLENO THERAPEUTICS INC | 120,449 | $8.6B | 7.76% | |
| 4 | AXSMAXSOME THERAPEUTICS INC | 72,113 | $8.4B | 7.58% | |
| 5 | TARSTARSUS PHARMACEUTICALS INC | 127,932 | $6.6B | 5.92% | |
| 6 | 2L9BLUEPRINT MEDICINES CORP | 74,192 | $6.6B | 5.92% | |
| 7 | IM8NINSMED INC | 85,110 | $6.5B | 5.85% | |
| 8 | AXSMAXSOME THERAPEUTICS INC | 50,000 | $5.8B | 5.26% | |
| 9 | TRVITREVI THERAPEUTICS INC | 686,219 | $4.3B | 3.89% | |
| 10 | PRAXPRAXIS PRECISION MEDICINES I | 95,582 | $3.6B | 3.26% | |
| 11 | CNTACENTESSA PHARMACEUTICALS-ADR | 243,086 | $3.5B | 3.15% | |
| 12 | ELVNENLIVEN THERAPEUTICS INC | 169,774 | $3.3B | 3.01% | |
| 13 | MRUSMERUS NV | 77,896 | $3.3B | 2.96% | |
| 14 | GONGERON CORP | 2,056,637 | $3.3B | 2.95% | |
| 15 | CGONCG ONCOLOGY INC | 132,298 | $3.2B | 2.92% | |
| 16 | ATYRATYR PHARMA INC | 777,020 | $2.3B | 2.12% | |
| 17 | TECXTECTONIC THERAPEUTIC INC | 132,222 | $2.3B | 2.11% | |
| 18 | XENEXENON PHARMACEUTICALS INC | 69,603 | $2.3B | 2.11% | |
| 19 | BRD1EURMIND MEDICINE MINDMED INC | 390,143 | $2.3B | 2.06% | |
| 20 | EWTXEDGEWISE THERAPEUTICS INC | 102,650 | $2.3B | 2.04% | |
| 21 | EWTXEDGEWISE THERAPEUTICS INC | 100,000 | $2.2B | 1.98% | |
| 22 | JANXJANUX THERAPEUTICS INC | 81,292 | $2.2B | 1.98% | |
| 23 | DNTHDIANTHUS THERAPEUTICS INC | 80,584 | $1.5B | 1.32% | |
| 24 | WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $1.5B | 1.31% | |
| 25 | KRROKORRO BIO INC | 59,723 | $1.0B | 0.94% | |
| 26 | PMNEURPROMIS NEUROSCIENCES INC | 1,484,699 | $1.0B | 0.93% | |
| 27 | TYRATYRA BIOSCIENCES INC | 107,244 | $997.4M | 0.90% | |
| 28 | CNTXCONTEXT THERAPEUTICS INC | 1,157,448 | $708.4M | 0.64% |